Kurtoglu Metin
SEC CIK 2000284 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RNAC | Cartesian Therapeutics, Inc. | CTO | 62.3K | — | $2.51M | 9 | 2024-01-02 | 2025-01-03 |
Most active insiders at RNAC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BARABE TIMOTHY C | Dir | $205.8K | — |
| 2 | Brunn Carsten | Pres, CEO, Dir | — | $162.1K |
| 3 | Davis Blaine | CFO | — | $72.2K |
| 4 | Miljkovic Milos | Chief Medical Off | — | $24.4K |
| 5 | Bot Adrian Ion | Dir | — | — |
| 6 | Seymour June Ann | CAO | — | — |
| 7 | English Emily | Chief Ops Off | — | — |
| 8 | Hoge Elizabeth | 10% | — | — |
| 9 | Singer Michael | Dir | — | — |
| 10 | Kalayoglu Murat | Dir, 10% | — | — |
Kurtoglu Metin made no open-market trades at RNAC in the last 12 months.
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-01-07 | 2025-01-03+ | RNAC | Cartesian Therapeutics, Inc. | Kurtoglu Metin | CTO | S - Sale | $16.78 | -4,875 | 62.3K | -7% | -$81.8K |
| D | 2025-01-06 | 2025-01-02 | RNAC | Cartesian Therapeutics, Inc. | Kurtoglu Metin | CTO | A - Grant | $0.00 | +16.1K | 67.1K | +32% | $0 |
| DM | 2024-12-11 | 2024-12-09+ | RNAC | Cartesian Therapeutics, Inc. | Kurtoglu Metin | CTO | M - OptEx | $1.41 | +13.7K | 53.9K | +34% | +$19.3K |
| DM | 2024-12-11 | 2024-12-09+ | RNAC | Cartesian Therapeutics, Inc. | Kurtoglu Metin | CTO | S - Sale+OE | $25.26 | -13.7K | 51.0K | -21% | -$345.1K |
| DM | 2024-11-21 | 2024-11-19+ | RNAC | Cartesian Therapeutics, Inc. | Kurtoglu Metin | CTO | S - Sale+OE | $16.78 | -38.7K | 51.0K | -43% | -$649.1K |
| DM | 2024-11-21 | 2024-11-19+ | RNAC | Cartesian Therapeutics, Inc. | Kurtoglu Metin | CTO | M - OptEx | $1.41 | +38.7K | 51.2K | +308% | +$54.6K |
| DM | 2024-11-18 | 2024-11-14+ | RNAC | Cartesian Therapeutics, Inc. | Kurtoglu Metin | CTO | S - Sale+OE | $17.46 | -82.4K | 51.0K | -62% | -$1.44M |
| DM | 2024-11-18 | 2024-11-14+ | RNAC | Cartesian Therapeutics, Inc. | Kurtoglu Metin | CTO | M - OptEx | $1.41 | +82.4K | 76.9K | New | +$116.1K |
| D | 2024-01-04 | 2024-01-02 | RNAC | Cartesian Therapeutics, Inc. | Kurtoglu Metin | COO | A - Grant | $0.00 | +1.53M | 1.53M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations